Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Johnson and Johnson
AstraZeneca
US Department of Justice
Cantor Fitzgerald
Harvard Business School

Generated: March 26, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Tirasemtiv

« Back to Dashboard

US Patents for Tirasemtiv

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tirasemtiv ➤ Try a Free Trial Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols, compositions thereof, and methods for their use Cytokinetics, Inc. (South San Francisco, CA) ➤ Try a Free Trial
Tirasemtiv ➤ Try a Free Trial Certain 1H-imidazo[4,5-B]pyrazin-2(3H)-ones and 1H-imidazo[4,5-B]pyrazin-2-ols, compositions thereof, and methods for their use Cytokinetics, Inc. (South San Francisco, CA) ➤ Try a Free Trial
Tirasemtiv ➤ Try a Free Trial Modulating skeletal muscle Cytokinetics, Inc. (South San Francisco, CA) ➤ Try a Free Trial
Tirasemtiv ➤ Try a Free Trial Certain chemical entities, compositions and methods Cytokinetics, Inc. (South San Francisco, CA) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Tirasemtiv

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Tirasemtiv Argentina 062196 2026-08-02 ➤ Try a Free Trial
Tirasemtiv Australia 2007281468 2026-08-02 ➤ Try a Free Trial
Tirasemtiv Brazil PI0714725 2026-08-02 ➤ Try a Free Trial
Tirasemtiv Canada 2659336 2026-08-02 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
US Army
Merck
Harvard Business School
Argus Health
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
 NCE-1 Generic Application Dates 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: